Skip to content

Cardiovascular Disease Early Detection and Prevention Act of 2026

In committee: it can still change before the session ends.

US HR 8260 · House Bill · 119th Congress

Stage
In committee
Started in
House
Sponsor
1
Latest action
Apr 14, 2026

What it does

The Cardiovascular Disease Early Detection and Prevention Act of 2026 would require group health plans, individual and group health insurance, Medicare, and Medicaid to cover lipoprotein(a) and apolipoprotein B testing without cost sharing for individuals with specific cardiovascular risk factors, such as family history of premature heart disease, prior heart attack or stroke, diabetes, obesity, or elevated LDL cholesterol. The bill amends the Public Health Service Act and titles XVIII and XIX of the Social Security Act to mandate this coverage and prohibit cost-sharing for these tests. It applies to plan years and services beginning 180 days after enactment. The legislation targets early…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Apr 14, 2026

  2. Committee (Current step)

    In committee · Apr 14, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Cardiovascular Disease Early Detection and Prevention Act of 2026 | 52